| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI119555 |
| P953 | full work available at URL | http://www.jci.org/articles/view/119555/files/pdf |
| https://europepmc.org/articles/PMC508212 | ||
| https://europepmc.org/articles/PMC508212?pdf=render | ||
| P932 | PMC publication ID | 508212 |
| P698 | PubMed publication ID | 9218526 |
| P50 | author | Hugo A. Katus | Q27929168 |
| Mathias Gautel | Q30169356 | ||
| P2093 | author name string | G. Mall | |
| C. Fischer | |||
| R. Dietz | |||
| W. Kübler | |||
| J. Zehelein | |||
| S. Labeit | |||
| B. Vollrath | |||
| W. Rottbauer | |||
| W. M. Franz | |||
| P2860 | cites work | Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy | Q24304076 |
| Titins: giant proteins in charge of muscle ultrastructure and elasticity | Q24312140 | ||
| Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere | Q24316399 | ||
| Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
| Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction? | Q24568292 | ||
| RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression | Q24633499 | ||
| Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3 | Q24679142 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 | ||
| Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
| Strategies for multilocus linkage analysis in humans | Q27860521 | ||
| Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy | Q28236892 | ||
| Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity | Q28256594 | ||
| A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation | Q28258622 | ||
| Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11 | Q28261884 | ||
| A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy | Q28278861 | ||
| Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy | Q28284626 | ||
| The 1993-94 Généthon human genetic linkage map | Q28288492 | ||
| Contractile protein mutations and heart disease | Q28288865 | ||
| Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy | Q28304526 | ||
| A mouse model of familial hypertrophic cardiomyopathy | Q28588233 | ||
| Drosophila melanogaster troponin-T mutations engender three distinct syndromes of myofibrillar abnormalities | Q33795649 | ||
| Pre-mRNA splicing | Q34559257 | ||
| Proteasomes: protein and gene structures | Q36090371 | ||
| A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. | Q36403852 | ||
| Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy | Q36437978 | ||
| Exon definition may facilitate splice site selection in RNAs with multiple exons | Q36713104 | ||
| The carboxyl terminus of myosin binding protein C (MyBP-C, C-protein) specifies incorporation into the A-band of striated muscle. | Q38363247 | ||
| Echocardiographic measurements in normal subjects: Evaluation of an adult population without clinically apparent heart disease | Q39704931 | ||
| Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). | Q39759074 | ||
| The anatomy of a molecular giant: how the sarcomere cytoskeleton is assembled from immunoglobulin superfamily molecules. | Q40415609 | ||
| Quantitative analysis in molecular diagnostics | Q40662676 | ||
| Cotranslational assembly of some cytoskeletal proteins: implications and prospects. | Q40774646 | ||
| A signaling pathway to translational control | Q41073792 | ||
| Assembly of cardiac C-protein during myofibrillogenesis in myogenic cells in culture. | Q42623781 | ||
| Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes | Q43724437 | ||
| Genetic dissection of Drosophila myofibril formation: effects of actin and myosin heavy chain null alleles. | Q52454750 | ||
| Echocardiographic measurements in normal subjects. Growth-related changes that occur between infancy and early adulthood | Q52798870 | ||
| A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. | Q55065766 | ||
| Fast and sensitive silver staining of DNA in polyacrylamide gels | Q67699472 | ||
| Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1 | Q69792543 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 475-82 | |
| P577 | publication date | 1997-07-15 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein | |
| P478 | volume | 100 |
| Q24645034 | A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia |
| Q35126714 | A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction |
| Q37385134 | A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy |
| Q35670306 | A novel variant of cardiac myosin-binding protein-C that is unable to assemble into sarcomeres is expressed in the aged mouse atrium |
| Q51060626 | AT1 blockade abolishes left ventricular hypertrophy in heterozygous cMyBP-C null mice: role of FHL1. |
| Q28252819 | Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice |
| Q33379935 | Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene |
| Q64232849 | Altered force generation and cell-to-cell contractile imbalance in hypertrophic cardiomyopathy |
| Q38295649 | Altered myocardial gene expression reveals possible maladaptive processes in heterozygous and homozygous cardiac myosin-binding protein C knockout mice |
| Q37526448 | Appetite for destruction: E3 ubiquitin-ligase protection in cardiac disease. |
| Q24309993 | Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms |
| Q63531533 | COOH-terminal truncated human cardiac MyBP-C alters myosin filament organization |
| Q47772454 | Cardiac Myosin-binding protein C and hypertrophic cardiomyopathy |
| Q35893509 | Cardiac myosin binding protein C insufficiency leads to early onset of mechanical dysfunction. |
| Q24294438 | Cardiac myosin binding protein C: its role in physiology and disease |
| Q36030150 | Cardiac myosin binding protein-C: redefining its structure and function |
| Q38584470 | Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology |
| Q38163334 | Cardiac myosin-binding protein C: hypertrophic cardiomyopathy mutations and structure-function relationships |
| Q64971291 | Cardiomyopathies and Related Changes in Contractility of Human Heart Muscle. |
| Q34444836 | Cardiomyopathies: from genetics to the prospect of treatment |
| Q28250082 | Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects |
| Q37629210 | Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy |
| Q28255924 | Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy |
| Q41700317 | Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes |
| Q37299072 | Designing heart performance by gene transfer. |
| Q28505121 | Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice |
| Q36303049 | Dissociation of structural and functional phenotypes in cardiac myosin-binding protein C conditional knockout mice |
| Q30500669 | Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice |
| Q24681653 | Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy |
| Q52551350 | Effect of extraction of myosin binding protein C on contractility of rat heart. |
| Q37394759 | Expression patterns of cardiac myofilament proteins: genomic and protein analysis of surgical myectomy tissue from patients with obstructive hypertrophic cardiomyopathy. |
| Q53664271 | Haploinsufficiency MYBPC3 mutations: another stress induced cardiomyopathy? Let's take a look! |
| Q28252351 | How do MYBPC3 mutations cause hypertrophic cardiomyopathy? |
| Q37855688 | How do mutations in contractile proteins cause the primary familial cardiomyopathies? |
| Q42515078 | Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy |
| Q28307598 | In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament |
| Q83821167 | Large-scale mutation screening in patients with dilated or hypertrophic cardiomyopathy: a pilot study using DGGE |
| Q28304022 | MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correction |
| Q37625105 | MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation |
| Q57807179 | Micro-exons of the cardiac myosin binding protein C gene: flanking introns contain a disproportionately large number of hypertrophic cardiomyopathy mutations |
| Q41706960 | Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death |
| Q34021080 | Molecular genetics and pathogenesis of hypertrophic cardiomyopathy |
| Q36344118 | Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease |
| Q34882653 | Molecular mechanisms of inherited cardiomyopathies |
| Q36299735 | Multiple forms of cardiac myosin-binding protein C exist and can regulate thick filament stability |
| Q27314792 | Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy. |
| Q22008775 | Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C |
| Q46523770 | Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle |
| Q35759293 | Myosin binding protein C: structural abnormalities in familial hypertrophic cardiomyopathy |
| Q35389621 | Myosin binding protein-C: a regulator of actomyosin interaction in striated muscle |
| Q37644780 | Phosphorylation and function of cardiac myosin binding protein-C in health and disease. |
| Q38970493 | Proteasome dysfunction in cardiomyopathies. |
| Q51573897 | Reduced cross-bridge dependent stiffness of skinned myocardium from mice lacking cardiac myosin binding protein-C. |
| Q28291547 | Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in mice |
| Q34696154 | Signaling and myosin-binding protein C. |
| Q52962652 | Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy. |
| Q27641388 | Structure, stability and dynamics of the central domain of cardiac myosin binding protein C (MyBP-C): implications for multidomain assembly and causes for cardiomyopathy |
| Q37821051 | The development of familial hypertrophic cardiomyopathy: from mutation to bedside |
| Q38699748 | The genetic basis of hypertrophic cardiomyopathy in cats and humans. |
| Q28144644 | The interface between MyBP-C and myosin: site-directed mutagenesis of the CX myosin-binding domain of MyBP-C |
| Q33939892 | The molecular genetic basis for hypertrophic cardiomyopathy |
| Q28252486 | The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy |
| Q88453324 | Thick Filament Protein Network, Functions, and Disease Association |
| Q73196351 | Variability in the ratio of mutant to wildtype myosin heavy chain present in the soleus muscle of patients with familial hypertrophic cardiomyopathy. A new approach for the quantification of mutant to wildtype protein |
| Q64975098 | Variable cardiac myosin binding protein-C expression in the myofilaments due to MYBPC3 mutations in hypertrophic cardiomyopathy. |
| Q74569442 | [Genetic causes of hypertrophic cardiomyopathy] |
| Q74043611 | [Genetically modified animal models in cardiovascular research] |
Search more.